A Massachusetts federal jury sided with lions McCarter & English LLP, Venable LLP, Williams & Connolly LLP and Minerva Law PC when it handed AstraZeneca PLC and Ranbaxy Inc. a win in the first pay-for-delay class action trial since the U.S. Supreme Court agreed the patent settlements could face antitrust scrutiny. The jury found that AstraZeneca would never have allowed a generic Nexium to launch before its medicine patents expired. AstraZeneca is represented by Dane H. Butswinkas and John E. Schmidtlein of Williams & Connolly LLP and William A. Zucker and Michael P. Kelly of McCarter & English LLP.
12.11.2014